Which pharmaceutical companies have the most SPCs in Germany?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Germany. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…


New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting…
The post New patent for Intra-cellular drug CAPLYTA appeared …


Biotechblog